Vbi Vaccines Stock Price To Sales
VBI Vaccines fundamentals help investors to digest information that contributes to VBI Vaccines' financial success or failures. It also enables traders to predict the movement of VBI Stock. The fundamental analysis module provides a way to measure VBI Vaccines' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to VBI Vaccines stock.
VBI |
VBI Vaccines Company Price To Sales Analysis
VBI Vaccines' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current VBI Vaccines Price To Sales | 0.20 X |
Most of VBI Vaccines' fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VBI Vaccines is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, VBI Vaccines has a Price To Sales of 0.199 times. This is 99.07% lower than that of the Biotechnology sector and 99.8% lower than that of the Health Care industry. The price to sales for all United States stocks is 98.26% higher than that of the company.
VBI Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses VBI Vaccines' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of VBI Vaccines could also be used in its relative valuation, which is a method of valuing VBI Vaccines by comparing valuation metrics of similar companies.VBI Vaccines is currently under evaluation in price to sales category among its peers.
VBI Fundamentals
Return On Equity | -4.2 | |||
Return On Asset | -0.29 | |||
Operating Margin | (9.68) % | |||
Current Valuation | 38.92 M | |||
Shares Outstanding | 28.68 M | |||
Shares Owned By Insiders | 6.76 % | |||
Shares Owned By Institutions | 13.00 % | |||
Number Of Shares Shorted | 276.87 K | |||
Price To Earning | (3.79) X | |||
Price To Book | 1.24 X | |||
Price To Sales | 0.20 X | |||
Revenue | 8.68 M | |||
Gross Profit | (10.19 M) | |||
EBITDA | (53.32 M) | |||
Net Income | (92.84 M) | |||
Cash And Equivalents | 82.41 M | |||
Cash Per Share | 0.32 X | |||
Total Debt | 53.04 M | |||
Debt To Equity | 0.32 % | |||
Current Ratio | 2.29 X | |||
Book Value Per Share | (0.22) X | |||
Cash Flow From Operations | (60.88 M) | |||
Short Ratio | 1.57 X | |||
Earnings Per Share | (3.54) X | |||
Target Price | 5.0 | |||
Number Of Employees | 131 | |||
Beta | 2.17 | |||
Market Capitalization | 1.87 M | |||
Total Asset | 86.95 M | |||
Retained Earnings | (582.45 M) | |||
Working Capital | (39.51 M) | |||
Current Asset | 7.89 M | |||
Current Liabilities | 3.03 M | |||
Net Asset | 86.95 M |
About VBI Vaccines Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VBI Vaccines's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VBI Vaccines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VBI Vaccines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in VBI Stock
If you are still planning to invest in VBI Vaccines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VBI Vaccines' history and understand the potential risks before investing.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |